Scripps MD Anderson Cancer Center 32nd Annual Cutaneous Malignancy Update Melanoma 2022

Scripps MD Anderson Cancer Center 32nd Annual Cutaneous Malignancy Update Melanoma 2022

$20.00

+ Include: 22 videos + 1 pdf, size: 3.07 GB

+ Target Audience: dermatologists, pathologists, dermatopathologists, primary care physican

Description

+ Include: 22 videos + 1 pdf, size: 3.07 GB

+ Target Audience: dermatologists, pathologists, dermatopathologists, primary care physican

+ Sample video: contact me for sample video

+ Information:

Conference Overview

As the incidence of melanoma continues to rise rapidly in the United States and around the world, the need to educate clinicians from various specialties on the disease also increases. During this course nationally recognized experts will present information on prevention, risk assessment, early detection, genetic factors, and current and future treatment choices for melanoma patients. Issues concerning surgical management, adjuvant therapy, advanced disease therapy, and personalizing the course of treatment for individual patients will also be discussed. This course is designed to provide information that will help clinicians in their decision making regarding these difficult patient problems. The course will be taught by a wide range of experts as this most serious of skin cancers will require multidisciplinary efforts to conquer.

Educational Objectives

After attending this live activity, participants should be able to:

• Describe the epidemiology and risk factors associated with the increasing incidence of cutaneous melanoma.

• Evaluate and diagnose a variety of malignancies related to melanoma skin cancer.

• Identify possible genetic mutations and etiologic factors in the melanoma patient and diagnose patients based on dermatologic manifestations.

• Integrate new therapies and treatments for advanced melanoma including surgical techniques.

• Discuss the effectiveness of neoadjuvant therapy and immunotherapy in treating melanoma.

• Develop strategies for managing patients with multiple melanomas.

Target Audience

• Dermatologists

• Pathologists

• Dermatopathologists

• Primary Care Physicians

• Dermatology Nurses/Nurse Practitioners/Physician Assistants

 

 

+ Topics:

brochure_mel2022_compressed.pdf

Case Presentations 1.mp4

Case Presentations 2.mp4

Case Presentations 3.mp4

Cutaneous Toxicities of Immune Therapy in Melanoma.mp4

Dermoscopy and New Diagnostic Techniques.mp4

Dysplastic Nevi.mp4

Evaluation of Melanonychia.mp4

Evaluation of the Melanoma Patient for Other Primary Melanoma Lesions.mp4

Melanoma Art and Science, Yesterday and Today.mp4

Melanoma Head and Neck Surgeon’s Perspective.mp4

Melanoma in the Molecular Age Part 1 New Tools for Diagnosis, Prognosis.mp4

Melanoma in the Molecular Age Part 2 New Tools for Diagnosis, Prognosis.mp4

Melanoma Medical Legal Complications.mp4

Metastatic Evaluation of the Melanoma Patient.mp4

Ministering to the Melanoma Patient.mp4

Neoadjuvant Therapy for Advanced Resectable Melanoma.mp4

Ocular and Periocular Melanoma.mp4

Oncolytic Immunotherapy.mp4

Pathology of Melanoma Current Status and Prognostic Indicators.mp4

Radiation Therapy for Melanoma Including Lentigo Maligna.mp4

Sentinel Node Evaluation.mp4

Treatment of Advanced Melanoma.mp4

Reviews

There are no reviews yet.

Be the first to review “Scripps MD Anderson Cancer Center 32nd Annual Cutaneous Malignancy Update Melanoma 2022”

Your email address will not be published. Required fields are marked *

Related Products